Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients

NCT04563013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2024-03-18

No results posted yet for this study

Summary

Patients diagnosed with breast cancer who received assisted radiotherapy were recruited and the transcutaneous auricular vagus nerve stimulation (taVNS) was applied. The aim of of study is : 1) to study whether taVNS could improve the patient's fatigue, quality of life under radiotherapy or chemotherapy; 2) to investigate the effects of taVNS on the levels of patients' lymphocyte subsets and proinflammatory cytokines.

Conditions

  • Breast Cancer
  • Cancer, Therapy-Related
  • Cancer-related Fatigue
  • Quality of Life

Interventions

DEVICE

Transcutaneous vagus nerve stimulation

the transcutaneous vagus nerve stimulation was conducted by ear clip with cathode and anode placed at the tragus for 30 min.

Sponsors & Collaborators

  • Air Force Military Medical University, China

    collaborator OTHER
  • Xidian University

    lead OTHER

Principal Investigators

  • Li-Na Zhao, Doctor · the First Affiliated Hospital of the Air Force Medical University

  • Wei Qin, Doctor · Xidian University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-23
Primary Completion
2022-04-30
Completion
2022-05-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04563013 on ClinicalTrials.gov